Talita Cavalcante Morais
Federal University of Ceará
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Talita Cavalcante Morais.
Chemico-Biological Interactions | 2010
Talita Cavalcante Morais; Natália Bitu Pinto; Karine Maria Martins Bezerra Carvalho; Jeison B. Rios; Nágila M.P.S. Ricardo; Maria Teresa Salles Trevisan; V. S. N. Rao; F. A. Santos
Cashew nut-shell liquid and the contained anacardic acids (AAs) have been shown to possess antioxidant, lipoxygenase inhibitory, anti-Helicobacter pylori and antitumor properties. Despite these known effects, hitherto there were no published reports on their likely gastroprotective effects. The present study was designed to verify whether AAs afford gastroprotection against the ethanol-induced gastric damage and to examine the underlying mechanism(s). Gastric damage was induced by intragastric administration of 0.2mL of ethanol (96%). Mice in groups were pretreated orally with AAs (10, 30 and 100mg/kg), misoprostol (50 microg/kg), or vehicle (2% Tween 80 in saline, 10mL/kg), 45min before ethanol administration. They were sacrificed 30min later, the stomachs excised, and the mucosal lesion area (mm(2)) measured by planimetry. Gastroprotection was assessed in relation to inhibition of gastric lesion area. To study the gastroprotective mechanism(s), its relations to capsaicin-sensitive fibers, endogenous prostaglandins, nitric oxide and ATP-sensitive potassium channels were analysed. Treatments effects on ethanol-associated oxidative stress markers GSH, MDA, catalase, SOD, and total nitrate/nitrite levels as an index of NO were measured in gastric tissue. Besides, the effects of AAs on gastric secretory volume and total acidity were analysed in 4-h pylorus-ligated rat. AAs afforded a dose-related gastroprotection against the ethanol damage and further prevented the ethanol-induced changes in the levels of GSH, MDA, catalase, SOD and nitrate/nitrite. However, they failed to modify the gastric secretion or the total acidity. It was observed that the gastroprotection by AAs was greatly reduced in animals pretreated with capsazepine, indomethacin, l-NAME or glibenclamide. These results suggest that AAs afford gastroprotection principally through an antioxidant mechanism. Other complementary mechanisms include the activation of capsaicin-sensitive gastric afferents, stimulation of endogenous prostaglandins and nitric oxide, and opening of K(+)(ATP) channels. These combined effects are likely to be accompanied by an increase in gastric microcirculation.
Phytomedicine | 2010
N.B. Pinto; Talita Cavalcante Morais; Karine Maria Martins Bezerra Carvalho; C.R. Silva; Geanne Matos de Andrade; Gerly Anne de Castro Brito; M.L. Veras; Otília Deusdênia L. Pessoa; V. S. N. Rao; F. A. Santos
The anti-inflammatory effect of physalin E, a seco-steroid isolated from Physalis angulata L. was evaluated on acute and chronic models of dermatitis induced by 12-O-tetradecanoyl-phorbol-13-acetate (TPA) and oxazolone, respectively, in mouse ear. The changes in ear edema/thickness, production of pro-inflammatory cytokines (TNF-alpha and IFN-gamma), myeloperoxidase (MPO) activity, and histological and immunohistochemical findings were analysed, as indicators of dermal inflammation. Similar to dexamethasone, topically applied Physalin E (0.125; 0.25 and 0.5 mg/ear) potently inhibited the TPA and oxazolone-induced dermatitis, leading to substantial reductions in ear edema/thickness, pro-inflammatory cytokines, and MPO activity. These effects were reversed by mifepristone, a steroid antagonist and confirmed by immunohistochemical and histopathological analysis. The data suggest that physalin E may be a potent and topically effective anti-inflammatory agent useful to treat the acute and chronic skin inflammatory conditions.
Pharmacological Reports | 2012
V. S. N. Rao; Ana Caroline Lustosa de Melo Carvalho; Maria Teresa Salles Trevisan; Geanne Matos de Andrade; Hélio Vitoriano Nobre Júnior; Manoel Odorico de Moraes; Hemerson I. Magalhães H. Iury; Talita Cavalcante Morais; F. A. Santos
BACKGROUND Accumulating evidence indicates that mangiferin (MGF), a natural xanthone, by virtue of its antioxidant and antiinflammatory properties is neuroprotective. Here we sought to verify the cytoprotective role of MGF on cultured rat primary mesencephalic cells exposed to 6-hydroxydopamine (6-OHDA) in vitro, and the MGFs anti-inflammatory potential in mouse model of ketamine-induced schizophrenia in vivo. METHODS 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)-assay was performed tomeasure cell viability inmesencephalic cell cultures exposed to neurotoxin (6-OHDA, 40 μM). Schizophrenia was induced in mice by ketamine (50 mg/kg, ip, twice a day, for 7 days). The treatment effects of MGF (50 mg/kg, po, for 7 days) were verified on locomotor behavioral changes in open-field test, and on the oxidant stress-related increase in lipid-peroxidation (malondialdehyde) and interleukin-6 (IL-6) levels in brain tissues. RESULTS MGF (10-100 μM) produced no per se effect on cell viability as measured by MTT assay, but significantly prevented the 6-OHDA-induced cell death in a concentration-dependent manner. Acridine orange/ethidium bromide (AO/EtBr) staining confirmed the absence of 6-OHDA-induced morphological changes characteristic of apoptosis/necrosis. In open-field test, ketamine-induced impaired locomotor activity and behavioral changes such as grooming and stereotyped but not rearing were effectively ameliorated by MGF pretreatment. Also, ketamine-associated increase in brain tissue levels of IL-6 and MDA were significantly lowered in MGF-pretreated mice. CONCLUSION Mangiferin has a neurocytoprotective role related, at least in part, to an antioxidant and anti-inflammatory mechanism, which could be explored for more effective therapies of schizophrenia and other neurodegenerative diseases.
World Journal of Gastroenterology | 2012
Talita Cavalcante Morais; Synara Cavalcante Lopes; Karine Maria Martins Bezerra Carvalho; Bruno Rodrigues Arruda; Francisco Thiago Correia de Souza; Maria Teresa Salles Trevisan; V. S. N. Rao; F. A. Santos
AIM To investigate the effects of mangiferin on gastrointestinal transit (GIT) in normal and constipated mice, together with the possible mechanism. METHODS Intragastrically-administered charcoal meal was used to measure GIT in overnight starved Swiss mice. In the first experiments, mangiferin (3 mg/kg, 10 mg/kg, 30 mg/kg, and 100 mg/kg, po) or tegaserod (1 mg/kg, ip) were administered 30 min before the charcoal meal to study their effects on normal transit. In the second series, mangiferin (30 mg/kg) was tested on delayed GIT induced by several different pharmacological agonists (morphine, clonidine, capsaicin) or antagonists (ondansetron, verapamil, and atropine) whereas in the third series, mangiferin (30 mg/kg, 100 mg/kg and 300 mg/kg) or tegaserod (1 mg/kg) were tested on 6 h fecal pellets outputted by freely fed mice. The ratio of wet to dry weight was calculated and used as a marker of fecal water content. RESULTS Mangiferin administered orally significantly (P < 0.05) accelerated GIT at 30 mg/kg and 100 mg/kg (89% and 93%, respectively), similarly to 5-hydroxytryptamine(4) (5-HT(4)) agonist tegaserod (81%) when compared to vehicle-treated control (63%). Co-administered mangiferin (30 mg/kg) totally reversed the inhibitory effect of opioid agonist morphine, 5-HT(3)-receptor antagonist ondansetron and transient receptor potential vanilloid-1 receptor agonist capsaicin on GIT, but only to a partial extent with the GIT-delay induced by α(2)-adrenoceptor agonist clonidine, and calcium antagonist verapamil. However, co-administered atropine completely blocked the stimulant effect of mangiferin on GIT, suggesting the involvement of muscarinic acetylcholine receptor activation. Although mangiferin significantly enhanced the 6 h fecal output at higher doses (245.5 ± 10.43 mg vs 161.9 ± 10.82 mg and 227.1 ± 20.11 mg vs 161.9 ± 10.82 mg of vehicle-treated control, at 30 and 100 mg/kg, P < 0.05, respectively), the effect of tegaserod was more potent (297.4 ± 7.42 mg vs 161.9 ± 10.82 mg of vehicle-treated control, P < 0.05). Unlike tegaserod, which showed an enhanced water content in fecal pellets (59.20% ± 1.09% vs 51.44% ± 1.19% of control, P < 0.05), mangiferin evidenced no such effect, indicating that it has only a motor and not a secretomotor effect. CONCLUSION Our data indicate the prokinetic action of mangiferin. It can stimulate the normal GIT and also overcome the drug-induced transit delay, via a cholinergic physiological mechanism.
Molecules | 2017
Paulo Carvalho de Paula; Daniele O. B. Sousa; J. M. Oliveira; Ana P. Carvalho; Bella Alves; Mirella L. Pereira; Davi Felipe Farias; Martônio Ponte Viana; F. A. Santos; Talita Cavalcante Morais; Ilka M. Vasconcelos
Moringa oleifera has been used in traditional medicine to treat diabetes. However, few studies have been conducted to relate its antidiabetic properties to proteins. In this study, a leaf protein isolate was obtained from M. oleifera leaves, named Mo-LPI, and the hypoglycemic and antioxidant effects on alloxan-induced diabetic mice were assessed. Mo-LPI was obtained by aqueous extraction, ammonium sulphate precipitation and dialysis. The electrophoresis profile and proteolytic hydrolysis confirmed its protein nature. Mo-LPI showed hemagglutinating activity, cross-reaction with anti-insulin antibodies and precipitation after zinc addition. Single-dose intraperitoneal (i.p.) administration of Mo-LPI (500 mg/kg·bw) reduced the blood glucose level (reductions of 34.3%, 60.9% and 66.4% after 1, 3 and 5 h, respectively). The effect of Mo-LPI was also evidenced in the repeated dose test with a 56.2% reduction in the blood glucose level on the 7th day after i.p. administration. Mo-LPI did not stimulate insulin secretion in diabetic mice. Mo-LPI was also effective in reducing the oxidative stress in diabetic mice by a decrease in malondialdehyde level and increase in catalase activity. Mo-LPI (2500 mg/kg·bw) did not cause acute toxicity to mice. Mo-LPI is a promising alternative or complementary agent to treat diabetes.
Revista Eletrônica de Farmácia | 2009
Francisca Cléa Florenço de Sousa; Talita Cavalcante Morais; Natália Bitu Pinto; Nayrton Flávio Moura Rocha; Marta Maria de França Fonteles; Silvânia Maria Mendes Vasconcelos; Glauce Socorro Barros Viana Viana; Danielle Silveira Macêdo
A cocaina e obtida das folhas do arbusto da coca (Erythroxylon coca) sendo utilizada como droga de abuso em diversas partes do mundo. Em doses exageradas (overdose) pode levar a convulsoes, falencia cardiaca ou depressao respiratoria, culminando com a morte. O objetivo deste trabalho foi levantar dados na literatura sobre: o envolvimento das monoaminas, participacao do estresse oxidativo e efeitos de psicofarmacos nas convulsoes induzidas por cocaina. Para isto, foi realizada revisao sistematica atraves do MEDLINE e PUBMED utilizando-se as seguintes palavras-chaves: cocaine, seizures, monoamines, oxidative stress e psychotropic drugs. Foram selecionados artigos publicados entre 1980 e 2007, que relacionavam cocaina com convulsoes em modelos animais. 10.5216/ref.v5i3.5374
World Journal of Gastroenterology | 2010
Caroline M. Melo; Karine Maria Martins Bezerra Carvalho; Julliana Catharina de Sousa Neves; Talita Cavalcante Morais; V. S. N. Rao; F. A. Santos; Gerly Anne de Castro Brito; Mariana H. Chaves
Biological & Pharmaceutical Bulletin | 2010
Karine Maria Martins Bezerra Carvalho; Talita Cavalcante Morais; Tiago Sousa de Melo; Gerly Anne de Castro Brito; Geanne Matos de Andrade; V. S. N. Rao; F. A. Santos
Inflammation Research | 2011
Caroline M. Melo; Talita Cavalcante Morais; Adriana da Rocha Tomé; Gerly Anne de Castro Brito; Mariana H. Chaves; V. S. N. Rao; F. A. Santos
Inflammopharmacology | 2009
Silvéria Regina de Sousa Lira; V. S. N. Rao; Ana Carla S. Carvalho; Marjorie M. Guedes; Talita Cavalcante Morais; Antonia L. de Souza; Maria Teresa Salles Trevisan; Alana F. Lima; Mariana H. Chaves; F. A. Santos